A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma-Reference-Cited by-同舟云学术

A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

Published:2024-01 Issue: Volume:196 Page:113436
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Habringer Stefan^ORCID,Demel Uta M.,Fietz Anne-Katrin^ORCID,Lammer Felicitas,Schroers Roland^ORCID,Hofer Silvia^ORCID,Bairey Osnat,Braess Jan^ORCID,Meier-Stiegen Anna Sofia,Stuhlmann Reingard,Schmidt-Hieber Martin,Hoffmann Johannes,Zinngrebe Bettina,Kaiser Ulrich,Reimer Peter,Möhle Robert,Fix Peter,Höffkes Heinz-Gert,Langenkamp Ulrich,Büschenfelde Christian Meyer zum,Hopfer Olaf,Stoltefuß Andrea,La Rosée Paul^ORCID,Blasberg Henning,Jordan Karin^ORCID,Kaun Stephan,Meurer Anna,Unteroberdörster Meike,von Brünneck Ann-Christin^ORCID,Capper David^ORCID,Heppner Frank L.,Chapuy Björn,Janz Martin^ORCID,Schwartz Stefan^ORCID,Konietschke Frank,Vajkoczy Peter,Korfel Agnieszka,Keller Ulrich^ORCID

Funder

Riemser Pharma GmbH

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients;Haioun;Groupe D′Etudes Des Lymphomes De l′Adulte Ann Oncol,2000

2. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model;Hollender;Ann Oncol,2002

3. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system;Jahnke;Ann Hematol,2006

4. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL);Boehme;Ann Oncol,2007

5. Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients;Wilson;Blood,2022